Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cholecystokinin and the hormone concept

    Research output: Contribution to journalReviewpeer-review

  2. Free testosterone and cardiometabolic parameters in men: comparison of algorithms

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Genotype-phenotype associations in PPGLs in 59 patients with variants in SDHX genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Levels of endocrine-disrupting chemicals are associated with changes in the peri-pubertal epigenome

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evidence for glucagon secretion and function within the human gut

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Glucagon and glucagon-like peptide-1 (GLP-1) originate from the common precursor, proglucagon, and their plasma concentrations have been reported to be increased during inflammatory conditions. Increased blood glucose levels are frequently observed in septic patients, and therefore we hypothesized that glucagon, but not GLP-1, is increased in individuals with inflammation.

DESIGN: Prospective longitudinal cohort study.

MATERIALS AND METHODS: We measured glucagon and GLP-1 in plasma sampled consecutively in three cohorts consisting of patients with infective endocarditis (n=16), urosepsis (n=28) and post-operative inflammation following percutaneous aortic valve implantation or thoracic endovascular aortic repair (n=5). Correlations between C-Reactive Protein (CRP), a marker of systemic inflammation, and glucagon and GLP-1 concentrations were investigated. Additionally, glucagon and GLP-1 concentrations were measured after a bolus infusion of lipopolysaccharide (LPS, 1ng/kg) in nine healthy young males.

RESULTS: Glucagon and CRP were positively and significantly correlated (r=0.27; P=0.0003), whereas no significant association between GLP-1 and CRP was found (r=0.08, P=0.30). LPS infusion resulted in acute systemic inflammation reflected by increased temperature, pulse, tumor necrosis factor-α (TNFα), interleukin-6 (IL-6) and concomitantly increased concentrations of glucagon (P<0.05) but not GLP-1.

CONCLUSIONS: Systemic inflammation caused by bacterial infections or developed as a non-infected condition is associated with increased plasma concentration of glucagon, but not GLP-1. Hyperglucagonemia may contribute to the impaired glucose control in patients with systemic inflammatory diseases.

Original languageEnglish
JournalEndocrine Connections
Volume10
Issue number2
Pages (from-to)205-213
Number of pages9
ISSN2049-3614
DOIs
Publication statusPublished - Feb 2021

ID: 62374897